Sponsor: Amgen
Learn more about the EVOLVE-MI trial or call the Reading Hospital Research Office at 484-628-8585 for more information.
EVOLVE-MI: Myocardial Infarction
A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction
